Alzamend Neuro Stock Market Value
| ALZN Stock | USD 0.67 0.03 4.29% |
| Symbol | Alzamend |
Alzamend Neuro Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Alzamend Neuro 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alzamend Neuro's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alzamend Neuro.
| 12/12/2024 |
| 03/12/2025 |
If you would invest 0.00 in Alzamend Neuro on December 12, 2024 and sell it all today you would earn a total of 0.00 from holding Alzamend Neuro or generate 0.0% return on investment in Alzamend Neuro over 90 days. Alzamend Neuro is related to or competes with Solid Biosciences, Kezar Life, Senti Biosciences, X4 Pharmaceuticals, Inozyme Pharma, Terns Pharmaceuticals, and Day One. Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the ... More
Alzamend Neuro Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alzamend Neuro's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alzamend Neuro upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 20.85 | |||
| Value At Risk | (7.29) | |||
| Potential Upside | 5.0 |
Alzamend Neuro Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alzamend Neuro's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alzamend Neuro's standard deviation. In reality, there are many statistical measures that can use Alzamend Neuro historical prices to predict the future Alzamend Neuro's volatility.| Risk Adjusted Performance | (0.18) | |||
| Jensen Alpha | (0.69) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | (0.84) |
Alzamend Neuro Backtested Returns
Alzamend Neuro secures Sharpe Ratio (or Efficiency) of -0.23, which signifies that the company had a -0.23 % return per unit of risk over the last 3 months. Alzamend Neuro exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alzamend Neuro's Mean Deviation of 2.7, risk adjusted performance of (0.18), and Standard Deviation of 3.67 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.97, which signifies possible diversification benefits within a given portfolio. Alzamend Neuro returns are very sensitive to returns on the market. As the market goes up or down, Alzamend Neuro is expected to follow. At this point, Alzamend Neuro has a negative expected return of -0.82%. Please make sure to confirm Alzamend Neuro's maximum drawdown, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Alzamend Neuro performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.42 |
Average predictability
Alzamend Neuro has average predictability. Overlapping area represents the amount of predictability between Alzamend Neuro time series from 12th of December 2024 to 26th of January 2025 and 26th of January 2025 to 12th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alzamend Neuro price movement. The serial correlation of 0.42 indicates that just about 42.0% of current Alzamend Neuro price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.42 | |
| Spearman Rank Test | 0.44 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Alzamend Neuro lagged returns against current returns
Autocorrelation, which is Alzamend Neuro stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Alzamend Neuro's stock expected returns. We can calculate the autocorrelation of Alzamend Neuro returns to help us make a trade decision. For example, suppose you find that Alzamend Neuro has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Alzamend Neuro regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Alzamend Neuro stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Alzamend Neuro stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Alzamend Neuro stock over time.
Current vs Lagged Prices |
| Timeline |
Alzamend Neuro Lagged Returns
When evaluating Alzamend Neuro's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Alzamend Neuro stock have on its future price. Alzamend Neuro autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Alzamend Neuro autocorrelation shows the relationship between Alzamend Neuro stock current value and its past values and can show if there is a momentum factor associated with investing in Alzamend Neuro.
Regressed Prices |
| Timeline |
When determining whether Alzamend Neuro offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alzamend Neuro's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alzamend Neuro Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alzamend Neuro Stock:
Check out Alzamend Neuro Correlation, Alzamend Neuro Volatility and Alzamend Neuro Alpha and Beta module to complement your research on Alzamend Neuro. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Alzamend Neuro technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.